Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03750981 · ClinicalTrials.gov registry record · NA
C.A.P.A.B.L.E. (CrossFit® and Physical Activity: A Better Life Experience)
A NA study of Cancer Survivors, sponsored by Barbara Ann Karmanos Cancer Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT03750981: Recruiting NA study of Cancer Survivors, sponsored by Barbara Ann Karmanos Cancer Institute.
NCT03750981 is a NA study of Cancer Survivors that is actively recruiting participants, run by Barbara Ann Karmanos Cancer Institute. The registered enrollment target is 500 participants, above the 72-participant average among 11 other Cancer Survivors trials with a reported enrollment target (594% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03750981, a NA study of Cancer Survivors, is actively recruiting participants, sponsored by Barbara Ann Karmanos Cancer Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will introduce cancer survivors to cross-training with the expectation that the program proposed will ultimately result in superior improvements in functional performance, body composition and quality of life compared with the current American Cancer Society (ACS) guidelines for cancer survivors.
Primary Outcome
Enrollment rates will be calculated among those who respond to notices about the study and adherence to the program among those who enroll and to describe reported barriers to participation among respondents who do not ultimately enroll
Conditions Studied
Interventions
- BEHAVIORAL 12 week pilot intervention study.
Study Locations (1)
Michigan
- Barbara Ann Karmanos Cancer Institute - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2018-11-12 |
| Est. Completion | 2028-11-30 |
| Phase | NA |
What NCT03750981 shows while recruiting
NCT03750981 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 72-participant average among 11 other Cancer Survivors trials with a reported enrollment target (594% higher).
The record links to 1 condition, with Cancer Survivors appearing as the primary indexed condition, and to 1 intervention - of which 12 week pilot intervention study. is the first listed.
NCT03750981 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT03750981 about?
NCT03750981 is a clinical study titled "C.A.P.A.B.L.E. (CrossFit® and Physical Activity: A Better Life Experience)". This study will introduce cancer survivors to cross-training with the expectation that the program proposed will ultimately result in superior improvements in functional performance, body composition and quality of life compared with the current American Cancer Society (ACS) guidelines for cancer su...
What is the current status of trial NCT03750981?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2018-11-12. Estimated completion is 2028-11-30.
What conditions does trial NCT03750981 study?
This clinical trial studies the following conditions: Cancer Survivors.
What interventions are being tested in trial NCT03750981?
The interventions under investigation include: 12 week pilot intervention study. (BEHAVIORAL).
Who is sponsoring clinical trial NCT03750981?
This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 139 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03750981 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer Survivors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03750981's enrollment target sits among peer trials
500 1st of 11 higher than 11 of 11 other Cancer Survivors trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer Survivors trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Personalized Exercise Prescriptions Through Mobile Health on Physical Activity and Health Outcomes in the Cancer Survivors
RECRUITING · NA
-
Targeted Telerehabilitation Following Curative Intent Therapy of Lung Cancer
RECRUITING · NA
-
Inspiratory Muscle Training in Obese Breast Cancer Survivors
RECRUITING · NA
-
Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors
RECRUITING · NA
-
Diaphragm Structure and Function in Childhood Cancer Survivors
RECRUITING · NA
-
SMLI With Hispanic Cancer Survivors and Caregivers
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI